[Studies of the effect of 5,5-diphenylhydantoin on the bioelectric activity of the brain in epilepsy].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D004569:Electroencephalography; D004827:Epilepsy / Q000188:drug therapy* / Q000503:physiopathology; D004832:Epilepsy, Absence / Q000503:physiopathology; D004834:Epilepsy, Post-Traumatic / Q000503:physiopathology; D004833:Epilepsy, Temporal Lobe / Q000503:physiopathology; D004830:Epilepsy, Tonic-Clonic / Q000503:physiopathology; D006801:Humans; D010672:Phenytoin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D010672:Phenytoin
Badania nad wpływem 5,5-dwufenylohydantoiny na czynność bioelektryczna mózgu w padaczce.